Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 30 Jun 2026 for Monte Rosa Therapeutics, Inc..
Filing timeline
BuySaleFilip Janku
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
No signal scores available.
Filip Janku: trading record in brief
Filip Janku discloses dealings in Monte Rosa Therapeutics, Inc. to SEC (Form 4). The record holds 10 filings, for trades running from 2 January 2025 to 29 June 2026.
Every open-market trade on record is a sale: 5 sales worth €1.1M. Other entries cover 2 share grants and 3 option exercises. In 2026 alone, the filings show no purchases and 5 sales.
The latest filing, published on 30 June 2026, reports an open-market sale of €121k in Monte Rosa Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Filip Janku
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
6,000 sharesCommon StockSEC:0001193125-26-290486:0
6,000 sharesCommon StockSEC:0001193125-26-290486:1
6,000 sharesCommon StockSEC:0001193125-26-282740:0
11,845 sharesCommon StockSEC:0001193125-26-282740:1
30,000 sharesCommon StockSEC:0001193125-26-282740:2
30,000 sharesCommon StockSEC:0001193125-26-282740:3
9,189 shares@ US$19.4973100.0% of flowCommon StockSEC:0001193125-26-066955:0
31,000 sharesCommon StockSEC:0001193125-26-002386:0
36,000 sharesCommon StockSEC:0000950170-25-002102:0
9 of 9 declarations
